Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD

Neurology

Volumn 55, Issue 5, 2000, Pages 684-688

  Jessen, Frank ^a   Block, W ^a   Traber F ^a   Keller, E ^a   Flacke, S ^a   Papassotiropoulos, A ^a   Lamerichs, R ^b   Heun, R ^a   Schild, H H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMETRY; TEMPORAL LOBE;

EID: 0033811153     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.5.684     Document Type: Article

References (38)

1. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro
2. Nuclear magnetic resonance spectroscopy: A review of neuropsychiatric applications
3. 1H spectroscopic imaging
4. Localized cerebral proton MR spectroscopy in HIV infection and AIDS
5. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo
6. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: Subgroup analysis and follow-up measurements
7. 1H NMR spectroscopy studies of Huntington's disease: Correlations with CAG repeat numbers
8. Neuropathological stageing of Alzheimer-related changes
9. Brain N-acetyl-L-aspartic acid in Alzheimer's disease: A proton magnetic resonance spectroscopy study
10. 1H NMR study of the hippocampus and cerebellum
11. N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases
12. 1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease
13. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study
14. Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia
15. 1H magnetic resonance spectroscopic imaging
16. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: Detection with proton MR spectroscopy
17. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy
18. In vivo proton magnetic resonance spectroscopy studies of human brain
19. Proton magnetic resonance spectroscopy in dementia of Alzheimer type
20. 1H MRS choline: Correlation with in vitro chemistry/histology
21. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline
22. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease
23. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
24. 'Mini-mental state': A practical method for grading the cognitive state of patients for the clinician
25. A new rating scale for Alzheimer's disease
26. Spatial localization in NMR spectroscopy
27. Double inversion recovery improves water suppression in vivo
28. 1H MRS study of probable Alzheimer's disease and normal aging: Implications for longitudinal monitoring of dementia progression
29. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging
30. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy
31. Alzheimer disease: Depiction of increased cerebral myoinositol with proton MR spectroscopy
32. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease
33. Probable Alzheimer disease: Diagnosis with proton MR spectroscopy
34. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease
35. Frontotemporal dementia and early Alzheimer disease: Differentiation with frontal lobe H-1 MR spectroscopy
36. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging
37. Alzheimer disease: Quantitative H-1 MR spectroscopic imaging of frontoparietal brain
38. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging